FOR
CDNA icon

Family Office Research’s CareDx CDNA Stock Holding History

Family Office Research’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-19,930
Closed -$389K – 73
2025
Q2 		$389K Hold
19,930
– – 0.18% 49
2025
Q1 		$354K Sell
19,930
-70,000
-78% -$1.51M 0.17% 49
2024
Q4 		$1.93M Buy
+89,930
New +$2.19M 0.84% 21

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Family Office Research's CDNA Position: Q3 2025 in Review

Family Office Research sold out of CareDx (CDNA) in Q3 2025, closing a stake of 19,930 shares — an estimated $389K sold.

Family Office Research first reported a position in CDNA in Q4 2024 and held it in 3 quarters. The position peaked at $1.93M in Q4 2024. 187 funds tracked by Wall St. Rank hold CDNA as of Q3 2025.

  • Family Office Research reported no remaining CareDx position as of Q3 2025 after selling out during the quarter.
  • Family Office Research sold 19,930 CareDx shares in Q3 2025, an estimated $389K.
  • Family Office Research first reported a position in CareDx in Q4 2024 and held it in 3 quarters.
  • Family Office Research's CareDx position peaked at $1.93M in Q4 2024.
  • 187 funds tracked by Wall St. Rank held CareDx as of Q3 2025.

Based on Family Office Research's 13F filing for Q3 2025, filed 4 Nov 2025.